BCM
MLNT

Bridgeway Capital Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bridgeway Capital Management’s Portfolio MLNT Stock Details MLNT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
2019
Q3 		$139K Buy
2018
Q4 		– Sell
2018
Q3 		$392K Hold
2018
Q2 		$631K Buy
2018
Q1 		$290K Sell
2017
Q4 		$1.24M Buy